BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Medh RD, Wang A, Zhou F, Thompson EB. Constitutive expression of ectopic c-Myc delays glucocorticoid-evoked apoptosis of human leukemic CEM-C7 cells. Oncogene 2001;20:4629-39. [PMID: 11498786 DOI: 10.1038/sj.onc.1204680] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Romero OA, Setien F, John S, Gimenez-Xavier P, Gómez-López G, Pisano D, Condom E, Villanueva A, Hager GL, Sanchez-Cespedes M. The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer. EMBO Mol Med 2012;4:603-16. [PMID: 22407764 DOI: 10.1002/emmm.201200236] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 4.7] [Reference Citation Analysis]
2 Miller AL, Johnson BH, Medh RD, Townsend CM, Thompson EB. Glucocorticoids and polyamine inhibitors synergize to kill human leukemic CEM cells. Neoplasia 2002;4:68-81. [PMID: 11922393 DOI: 10.1038/sj.neo.7900208] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
3 Rainer J, Lelong J, Bindreither D, Mantinger C, Ploner C, Geley S, Kofler R. Research resource: transcriptional response to glucocorticoids in childhood acute lymphoblastic leukemia. Mol Endocrinol 2012;26:178-93. [PMID: 22074950 DOI: 10.1210/me.2011-1213] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
4 Khan SH, Jasuja R, Kumar R. Trehalose induces functionally active conformation in the intrinsically disordered N-terminal domain of glucocorticoid receptor. Journal of Biomolecular Structure and Dynamics 2017;35:2248-56. [DOI: 10.1080/07391102.2016.1214086] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
5 Lambrou GI, Papadimitriou L, Chrousos GP, Vlahopoulos SA. Glucocorticoid and proteasome inhibitor impact on the leukemic lymphoblast: multiple, diverse signals converging on a few key downstream regulators. Mol Cell Endocrinol 2012;351:142-51. [PMID: 22273806 DOI: 10.1016/j.mce.2012.01.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
6 Laakko T, Schwartz RC, Fraker PJ. IL-7-mediated protection of pro and pre-B cells from the adverse effects of corticosterone. Cell Immunol 2002;220:39-50. [PMID: 12718938 DOI: 10.1016/s0008-8749(03)00023-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
7 Cakir M, Mukherjee S, Wood KC. Label propagation defines signaling networks associated with recurrently mutated cancer genes. Sci Rep 2019;9:9401. [PMID: 31253832 DOI: 10.1038/s41598-019-45603-3] [Reference Citation Analysis]
8 Medh RD. Microarray-based expression profiling of normal and malignant immune cells. Endocr Rev 2002;23:393-400. [PMID: 12050128 DOI: 10.1210/edrv.23.3.0470] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
9 Robak P, Drozdz I, Szemraj J, Robak T. Drug resistance in multiple myeloma. Cancer Treatment Reviews 2018;70:199-208. [DOI: 10.1016/j.ctrv.2018.09.001] [Cited by in Crossref: 90] [Cited by in F6Publishing: 84] [Article Influence: 22.5] [Reference Citation Analysis]
10 Tissing WJ, Meijerink JP, den Boer ML, Pieters R. Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia. Leukemia. 2003;17:17-25. [PMID: 12529655 DOI: 10.1038/sj.leu.2402733] [Cited by in Crossref: 108] [Cited by in F6Publishing: 107] [Article Influence: 5.7] [Reference Citation Analysis]
11 Sifakis EG, Lambrou GI, Prentza A, Vlahopoulos S, Koutsouris D, Tzortzatou-Stathopoulou F, Chatziioannou AA. Elucidating the identity of resistance mechanisms to prednisolone exposure in acute lymphoblastic leukemia cells through transcriptomic analysis: A computational approach. J Clin Bioinforma 2011;1:36. [PMID: 22185641 DOI: 10.1186/2043-9113-1-36] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
12 Igarashi H, Medina KL, Yokota T, Rossi MI, Sakaguchi N, Comp PC, Kincade PW. Early lymphoid progenitors in mouse and man are highly sensitive to glucocorticoids. Int Immunol 2005;17:501-11. [PMID: 15746243 DOI: 10.1093/intimm/dxh230] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 3.0] [Reference Citation Analysis]
13 Bhadri VA, Cowley MJ, Kaplan W, Trahair TN, Lock RB. Evaluation of the NOD/SCID xenograft model for glucocorticoid-regulated gene expression in childhood B-cell precursor acute lymphoblastic leukemia. BMC Genomics 2011;12:565. [PMID: 22093874 DOI: 10.1186/1471-2164-12-565] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
14 Ausserlechner MJ, Obexer P, Böck G, Geley S, Kofler R. Cyclin D3 and c-MYC control glucocorticoid-induced cell cycle arrest but not apoptosis in lymphoblastic leukemia cells. Cell Death Differ 2004;11:165-74. [DOI: 10.1038/sj.cdd.4401328] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
15 Miller AL, Webb MS, Copik AJ, Wang Y, Johnson BH, Kumar R, Thompson EB. p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Mol Endocrinol 2005;19:1569-83. [PMID: 15817653 DOI: 10.1210/me.2004-0528] [Cited by in Crossref: 157] [Cited by in F6Publishing: 162] [Article Influence: 9.2] [Reference Citation Analysis]
16 Priceman SJ, Kirzner JD, Nary LJ, Morris D, Shankar DB, Sakamoto KM, Medh RD. Calcium-dependent upregulation of E4BP4 expression correlates with glucocorticoid-evoked apoptosis of human leukemic CEM cells. Biochem Biophys Res Commun 2006;344:491-9. [PMID: 16630563 DOI: 10.1016/j.bbrc.2006.03.169] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
17 Yan M, Kuang X, Scofield VL, Shen J, Lynn WS, Wong PK. The glucorcorticoid receptor is increased in Atm−/− thymocytes and in Atm−/− thymic lymphoma cells, and its nuclear translocation counteracts c-myc expression. Steroids 2007;72:415-21. [DOI: 10.1016/j.steroids.2007.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
18 Schmidt S, Rainer J, Riml S, Ploner C, Jesacher S, Achmüller C, Presul E, Skvortsov S, Crazzolara R, Fiegl M, Raivio T, Jänne OA, Geley S, Meister B, Kofler R. Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia. Blood 2006;107:2061-9. [PMID: 16293608 DOI: 10.1182/blood-2005-07-2853] [Cited by in Crossref: 108] [Cited by in F6Publishing: 98] [Article Influence: 6.4] [Reference Citation Analysis]
19 Tome ME, Lutz NW, Briehl MM. Overexpression of catalase or Bcl-2 alters glucose and energy metabolism concomitant with dexamethasone resistance. Biochim Biophys Acta 2004;1693:57-72. [PMID: 15276325 DOI: 10.1016/j.bbamcr.2004.05.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
20 Sionov RV. MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies. ISRN Hematol. 2013;2013:348212. [PMID: 23431463 DOI: 10.1155/2013/348212] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
21 Li J, Zou J, Wan X, Sun C, Chu Z, Hu Y. Roles of noncoding RNAs in drug resistance in multiple myeloma. J Cell Physiol 2020;235:7681-95. [PMID: 32324301 DOI: 10.1002/jcp.29726] [Reference Citation Analysis]
22 Chen DW, Saha V, Liu JZ, Schwartz JM, Krstic-Demonacos M. Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia. Oncogene 2013;32:3039-48. [PMID: 22869147 DOI: 10.1038/onc.2012.321] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
23 Webb MS, Miller AL, Howard TL, Johnson BH, Chumakov S, Fofanov Y, Nguyen-Vu T, Lin CY, Thompson EB. Sequential gene regulatory events leading to glucocorticoid-evoked apoptosis of CEM human leukemic cells:interactions of MAPK, MYC and glucocorticoid pathways. Mol Cell Endocrinol 2018;471:118-30. [PMID: 29596968 DOI: 10.1016/j.mce.2018.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
24 Wang Z, Malone MH, He H, McColl KS, Distelhorst CW. Microarray analysis uncovers the induction of the proapoptotic BH3-only protein Bim in multiple models of glucocorticoid-induced apoptosis. J Biol Chem 2003;278:23861-7. [PMID: 12676946 DOI: 10.1074/jbc.M301843200] [Cited by in Crossref: 162] [Cited by in F6Publishing: 69] [Article Influence: 8.5] [Reference Citation Analysis]
25 Miller AL, Geng C, Golovko G, Sharma M, Schwartz JR, Yan J, Sowers L, Widger WR, Fofanov Y, Vedeckis WV, Thompson EB. Epigenetic alteration by DNA-demethylating treatment restores apoptotic response to glucocorticoids in dexamethasone-resistant human malignant lymphoid cells. Cancer Cell Int 2014;14:35. [PMID: 24795534 DOI: 10.1186/1475-2867-14-35] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
26 Ji Z, Mei FC, Johnson BH, Thompson EB, Cheng X. Protein kinase A, not Epac, suppresses hedgehog activity and regulates glucocorticoid sensitivity in acute lymphoblastic leukemia cells. J Biol Chem 2007;282:37370-7. [PMID: 17895245 DOI: 10.1074/jbc.M703697200] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
27 Thompson EB. Stepping stones in the path of glucocorticoid-driven apoptosis of lymphoid cells. Acta Biochimica et Biophysica Sinica 2008;40:595-600. [DOI: 10.1111/j.1745-7270.2008.00433.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
28 Liu Y, Ge J, Li Q, Guo X, Gu L, Ma Z, Li X, Zhu Y. Low-dose anisomycin sensitizes glucocorticoid-resistant T-acute lymphoblastic leukemia CEM-C1 cells to dexamethasone-induced apoptosis through activation of glucocorticoid receptor and p38-MAPK/JNK. Leukemia & Lymphoma 2014;55:2179-88. [DOI: 10.3109/10428194.2013.866664] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
29 Garza AS, Miller AL, Johnson BH, Thompson EB. Converting cell lines representing hematological malignancies from glucocorticoid-resistant to glucocorticoid-sensitive: signaling pathway interactions. Leuk Res 2009;33:717-27. [PMID: 19012965 DOI: 10.1016/j.leukres.2008.10.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
30 Domínguez-cáceres MA, García-martínez JM, Calcabrini A, González L, Porque PG, León J, Martín-pérez J. Prolactin induces c-Myc expression and cell survival through activation of Src/Akt pathway in lymphoid cells. Oncogene 2004;23:7378-90. [DOI: 10.1038/sj.onc.1208002] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 2.8] [Reference Citation Analysis]
31 Rees-Unwin KS, Craven RA, Davenport E, Hanrahan S, Totty NF, Dring AM, Banks RE, J Morgan G, Davies FE. Proteomic evaluation of pathways associated with dexamethasone-mediated apoptosis and resistance in multiple myeloma. Br J Haematol 2007;139:559-67. [PMID: 17979943 DOI: 10.1111/j.1365-2141.2007.06837.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
32 Schwartz JR, Sarvaiya PJ, Vedeckis WV. Glucocorticoid receptor knock down reveals a similar apoptotic threshold but differing gene regulation patterns in T-cell and pre-B-cell acute lymphoblastic leukemia. Mol Cell Endocrinol 2010;320:76-86. [PMID: 20170710 DOI: 10.1016/j.mce.2010.02.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]